Država: Novi Zeland
Jezik: engleski
Izvor: Medsafe (Medicines Safety Authority)
Diflucortolone valerate 0.1%
LEO Pharma Limited
Diflucortolone valerate 0.1%
0.1 %
Topical cream
Active: Diflucortolone valerate 0.1% Excipient: Carbomer Disodium edetate dihydrate Liquid paraffin Macrogol stearate 2000 Methyl hydroxybenzoate Propyl hydroxybenzoate Purified water Sodium hydroxide Stearyl alcohol White soft paraffin
Tube, aluminium, 1x50g, 50 g
Prescription
Prescription
Bayer Pharma AG
All skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites.
Package - Contents - Shelf Life: Tube, aluminium, - 50 g - 36 months from date of manufacture stored at or below 25°C 3 months opened stored at or below 25°C
1976-06-10
CONSUMER MEDICINE INFORMATION NERISONE ® _Cream: 1 g cream contains 1 mg diflucortolone valerate. _ _Fatty Ointment: 1 g fatty ointment contains 1 mg diflucortolone valerate. _ WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start using Nerisone ® . It will advise you about how to use Nerisone ® properly and when to tell your doctor about health-related conditions. If you have any questions or need more advice, ask your doctor, professional health care provider or pharmacist. This preparation has been prescribed for you personally and you should not pass it on to others. It may harm them. Keep this leaflet with the medicine. You may need to read it again. WHAT IS NERISONE ® USED FOR Nerisone ® is an anti-inflammatory medicine (a corticosteroid) for use on the skin. Nerisone ® treats inflammatory and allergic skin reactions (eg. eczema) that can cause redness, swelling, itchiness or soreness. It can also be used to treat first degree burns, sunburn and insect bites. Nerisone ® is available in two different formulations: • Nerisone ® cream Nerisone ® cream is particularly suitable for weeping skin conditions (ie. skin producing fluid), and for use on exposed or hairy parts of the body. • Nerisone ® fatty ointment Nerisone ® fatty ointment is particularly suitable for very dry skin conditions or skin conditions that have been occurring for a long time. BEFORE YOU USE NERISONE ® Do not use Nerisone ® if you have any of the conditions listed below. If any of these apply to you, tell your doctor before starting to use Nerisone ® . _ _ _YOU MUST NOT USE NERISONE_ _®_ _ IF: _ • You are hypersensitive (allergic) to diflucortolone valerate or any of the other ingredients of Nerisone ® as listed under FURTHER INFORMATION. • You are suffering from tuberculosis or syphilis in the area to be treated. • You are suffering from a viral disease (eg. chicken-pox or shingles). • You have had a skin reaction after vaccination in the area to be treated. • You have acne, rosacea (skin Pročitajte cijeli dokument
NEW ZEALAND DATA SHEET Page 1 of 6 1 NERISONE® NERISONE® Diflucortolone valerate 0.1 % fatty ointment NERISONE® Diflucortolone valerate 0.1 % cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION NERISONE® Cream: 1 g white cream contains 1 mg (0.1 %) diflucortolone valerate. The cream is an oil-in-water emulsion containing approximately 70% water. NERISONE® Fatty Ointment: 1 g white single-phase fatty ointment contains 1 mg (0.1 %) diflucortolone valerate. NERISONE® Fatty Ointment contains methyl parahydroxybenzoate and propyl parahydroxybenzoate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Topical cream Topical fatty ointment 4 CLINICAL PARTICULARS 4.1 Therapeutic indications All skin diseases which respond to topical corticoid therapy (eg): contact dermatitis, contact eczema, occupational eczema vulgar, nummular, degenerative and seborrhoeic eczema, dyshidrotic eczema, eczema in varicose syndrome (but not directly onto lower limb ulcers), anal eczema, eczema in children, neurodermatitis (endogenous eczema, atopic dermatitis), psoriasis, lichen ruber planus et verrucosus, lupus erythematosus discoides, first degree burns, sunburn, insect bites. 4.2 Dose and method of administration At the beginning of treatment, the NERISONE® preparation best suited to the skin condition is applied thinly two or perhaps three times per day. Once the clinical picture has improved, one application per day usually suffices. NERISONE® is available as a cream and a fatty ointment. Which form should be used in the individual case will depend on the appearance of the skin: NERISONE® CREAM in weeping skin conditions and NERISONE® FATTY OINTMENT in very dry skin conditions. NERISONE® CREAM has a high water and low fat content. In weeping skin diseases it allows secretions to drain away, thus providing for rapid subsidence and drying up of the skin. It is also suitable for application to moist, exposed and hairy areas of the body. If the skin dries out too much under protracted use of NERISONE® CREAM, th Pročitajte cijeli dokument